openPR Logo
Press release

Dr. Anil Shah of Noses and Necks New York Publishes Groundbreaking Study on Tranexamic Acid's Effects on Postoperative Bruising in Rhinoplasty

01-08-2025 11:02 PM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Dr. Anil Shah of Noses and Necks New York Publishes

New York, NY - Dr. Anil Shah, a world-renowned facial plastic surgeon and founder of Noses and Necks New York, has recently published a critical study titled "Quantitative Analysis of Tranexamic Acid Effects on Ecchymosis in Rhinoplasty [https://pubmed.ncbi.nlm.nih.gov/34166107/]" in the National Institutes of Health. This prospective study sheds new light on the controversial use of tranexamic acid (TXA) to reduce postoperative bruising in rhinoplasty patients.

Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXfVDbQhOFinOcBSQ5nciUm9DsoD0NuLoFpx2pRpJKlGwF1ShuxrRtoHzCmlj3nF_1a1ES5UNmpf9ecMcjgwmLFxHHsqGSy8GVtatSL9uP9vz3LpKW6q2_zS8by6t2BR_bZgX1wSag?key=Pz0acybvlnlB0bcyvyXGyV6t

Study Overview

Rhinoplasty, one of the most popular cosmetic surgeries, often comes with postoperative challenges such as bruising (ecchymosis), which can impact patient satisfaction and recovery timelines. Tranexamic acid, widely discussed for its potential to reduce bruising, has remained a contentious topic among surgeons due to its associated risks, including seizures, blood clots, and vision changes.

Dr. Shah's study, conducted between March and June 2019, focused on a group of 100 primary rhinoplasty patients-50 of whom were treated with TXA while the remaining 50 served as a control group. Using advanced quantitative methods, including Adobe Photoshop's multiple objective color scales, Dr. Shah and his team measured and analyzed postoperative bruising on day 7 after surgery.

Key Findings

*
There were no statistically significant differences in postoperative bruising between patients treated with TXA and those in the control group.

*
No adverse events related to TXA, such as seizures or vision changes, were reported in this study.

*
TXA, administered intravenously and via intraoperative injections, did not demonstrate efficacy in reducing postoperative bruising in rhinoplasty.

Impact and Implications

"This study highlights the importance of evidence-based decision-making in plastic surgery," said Dr. Shah. "While tranexamic acid remains an option for some surgeons, its efficacy in reducing bruising during rhinoplasty does not appear to be supported by quantitative data. It's crucial to balance patient safety with outcomes, especially when considering interventions with potential side effects."

The study is a milestone in promoting transparency and data-driven practices in facial plastic surgery. Dr. Shah's use of advanced imaging technology for quantitative analysis provides a replicable methodology for future research into postoperative outcomes.

About Dr. Anil Shah

Dr. Anil Shah is a double board-certified facial plastic surgeon and founder of Noses and Necks New York [https://www.nosesandnecksnyc.com/], a premier plastic surgery practice in Manhattan, Park Avenue, specializing in innovative facial and neck procedures. With an extensive background in clinical research and a reputation for surgical excellence, Dr. Shah continues to set the standard for safety, artistry, and patient-centered care in facial plastic surgery.

For more information or to schedule an interview with Dr. Anil Shah, please contact:

Dr. Anil Shah, MD

Noses and Necks NYC

60 East 56th Street, Suite 304

New York, NY 10022

Phone: 646.798.4905

Email-1: shahmddesign@gmail.com

Email-2: practicemanager@shahmd.com

Media Contact
Company Name: Noses and Necks NYC
Contact Person: Aurora Z
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dr-anil-shah-of-noses-and-necks-new-york-publishes-groundbreaking-study-on-tranexamic-acids-effects-on-postoperative-bruising-in-rhinoplasty]
Country: United States
Website: https://www.nosesandnecksnyc.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Anil Shah of Noses and Necks New York Publishes Groundbreaking Study on Tranexamic Acid's Effects on Postoperative Bruising in Rhinoplasty here

News-ID: 3808224 • Views:

More Releases from ABNewswire

Alopecia Areata Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Pfizer, Suzhou Zelgen Biopharma, Eli Lilly, Incyte, Throne Biotech, Legacy Healthcare
Alopecia Areata Market to Witness Promising Upswing by 2034, DelveInsight Foreca …
The Key Alopecia Areata Companies in the market include - Eli Lilly and Company/Incyte Corporation, Pfizer, Legacy Healthcare, Pfizer, Q32 Bio Inc., AbbVie, Amgen, Concert Pharmaceuticals, Bristol-Myers Squibb, Reistone Biopharma, Inmagene LLC, Suzhou Zelgen Biopharma, Nektar Therapeutics, AnaptysBio, Inc., LEO Pharma, Eli Lilly and Company, and others. The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage
Neko Case Neon Grey Midnight Green 2026: Affordable Tickets + CITY10 Code for Instant Savings
Neko Case Neon Grey Midnight Green 2026: Affordable Tickets + CITY10 Code for In …
Neko Case's Neon Grey Midnight Green Tour rocks North America in 2026, celebrating her acclaimed Sept 2025 album-first new solo work since 2018-with raw, live-recorded tracks, powerful vocals, and hits like "Hold On, Hold On." Catch her with Des Demonas (East/Midwest) or Destroyer (West) from Jan 8 Montreal to March dates in CO, CA & more! Neko Case [https://www.capitalcitytickets.com/Neko-Case-Tickets] is embarking on her electrifying Neon Grey Midnight Green Tour in 2026,
Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside: ADMQ, BMXI, CSDX, SIGL
Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside …
Toogood Gold Corp. (TSXV: TGC | OTCQB: TGGCF) reported final drilling assays from its 100%-owned Toogood Gold Project in Newfoundland, delivering results that significantly expand the scale, continuity, and upside potential of its gold discovery heading into 2026. The Company's 2025 drill program confirmed the Quinlan target as a large, coherent gold system, with gold intersected in all 30 drill holes completed to date. High-grade intervals and visible gold were reported
Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eli Lilly and Company, Bayer, Zymeworks, Jazz Pharma, Amgen, AstraZeneca, Symphogen, Hoffmann-La Roche
Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveIn …
The Key Esophageal Cancer Companies in the market include - Eli Lilly and Company, Bayer, Zymeworks, Jazz Pharmaceuticals, Amgen, Jazz Pharmaceuticals, Zymeworks, BeiGene, AstraZeneca, Symphogen, Hoffmann-La Roche, Eli Lilly and Company, Ipsen, Jacobio Pharmaceuticals Co., Ltd., Shanghai Henlius Biotech, CStone Pharmaceuticals, Novartis Pharmaceuticals, Sanofi, Seagen Inc., Rapa Therapeutics LLC, Incyte Corporation, Atreca, Inc., and others. DelveInsight's "Esophageal Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the

All 5 Releases


More Releases for Shah

Dr. Anil Shah Introduces Revolutionary Suture Suspension Technique for Crooked N …
New York, NY - Board-certified facial plastic surgeon Dr. Anil Shah is redefining how surgeons treat one of the most difficult nasal deformities: the crooked nose. With his innovative Suture Suspension Technique [https://www.shahfacialplastics.com/articles/crooked-nose-suture-suture-suspension-technique/], Dr. Shah offers a minimally invasive, highly effective solution that avoids many of the limitations associated with traditional rhinoplasty. The crooked nose, often caused by trauma or congenital asymmetries, has historically been a surgical challenge. Traditional techniques involve
Decoding Shah Equity: Why Noorullah Shah Hussaini Won't Sell His Cash-Printing A …
Image: https://www.globalnewslines.com/uploads/2025/06/9c8ad684657ef744f136e9aead513463.jpg The marble foyer of the Emirates Palace still hummed with post-conference chatter when Noorullah Shah Hussaini agreed to sit down for what he calls a "rare public debrief." Moments earlier the twenty-one-year-old founder of Shah Equity had speed-dated with a number of family offices at the Annual Family Office Summit in Abu Dhabi, where delegates from Riyadh to Singapore had quizzed him on topics ranging from the latest weight
Dipesh Shah, USFDA Inspector: Key Reports and Regulatory Actions
Dipesh Shah has had a prominent role in ensuring regulatory compliance within the pharmaceutical industry. With 191 inspections and 163 Form 483s issued, his inspection history highlights the critical importance of maintaining strict adherence to FDA standards. This article explores the key aspects of Shah's inspections, including his role in issuing warning letters, the duration of his inspections, and the global scope of his work. We'll also look at what
Shah Equity & Shah Health Partners: Transforming Healthcare in the Gulf
A groundbreaking collaboration between Shah Equity and Wafra International Investments has sent ripples through the Middle Eastern healthcare sector. This bold venture-a $50 million pension hospital project in Kuwait-combines cutting-edge clinical expertise, solidified financial backing, and a keen focus on high-impact specialties. At its core, Shah Equity's healthcare subsidiary, Shah Health Partners, will manage and acquire the hospital's gastrointestinal (GI) department, highlighting a pivotal moment in Gulf-region medicine. "Healthcare in the
Dr. Anil Shah Publishes Comprehensive Article on "The Aging Face"
New York, NY - January 16, 2025 - Renowned NYC, Manhattan, Park Avenue-based facial plastic surgeon Dr. Anil Shah, along with co-author Dr. Paige M. Kennedy, published the groundbreaking article "The Aging Face [https://pubmed.ncbi.nlm.nih.gov/30342607/]," which has become a cornerstone in understanding the biological and physical foundations of facial aging. The article, published in the National Institutes of Health, provides an in-depth look into the complex factors that contribute to facial
Ali Asghar Shah Drops New Track "Don't Stop Believin"
Pakistani singer, songwriter and producer Ali Asghar Shah released his latest song "Don`t Stop Believin". This is one of the first songs that Ali plans to release in 2021. Three years later, he introduced the idea of the project by releasing a new version of the song, showing that the art was never really completed and celebrating the process of becoming an artist. . "Don't stop believing" this song is